ID   HROC285 T0 M2
AC   CVCL_1U92
SY   HROC285
DR   CLS; 300817
DR   Wikidata; Q54895277
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Doubling time: 29 hours (CLS=300817).
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Colon, descending; UBERON=UBERON_0001158.
DI   NCIt; C4349; Colon adenocarcinoma
DI   NCIt; C8494; Lynch syndrome
DI   ORDO; Orphanet_144; Lynch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6AW ! B-LCL-HROC285
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
RX   PubMed=31601052; DOI=10.3390/cancers11101520; PMCID=PMC6826890;
RA   Mullins, Christina Susanne
RA   Micheel, Bianca
RA   Matschos, Stephanie
RA   Leuchter, Matthias
RA   Burtin, Florian
RA   Krohn, Mathias
RA   Huhns, Maja
RA   Klar, Ernst
RA   Prall, Friedrich
RA   Linnebacher, Michael
RT   "Integrated biobanking and tumor model establishment of human
RT   colorectal carcinoma provides excellent tools for preclinical
RT   research.";
RL   Cancers (Basel) 11:1520.1-1520.18(2019).
//